Toe gangrene is one of the most consequential complications of diabetic foot disease. Clinicians and patients often ask whether a dry, blackened toe should be removed promptly or left to separate on its own, a process known as autoamputation. The published evidence on this question is limited, mostly retrospective, and drawn from small series. This article summarizes what that literature does and does not establish.
Dry Versus Wet Gangrene: Why the Distinction Matters
Dry gangrene typically reflects tissue death from inadequate arterial perfusion, while wet gangrene involves superimposed infection. The two carry different risks. In a single-centre retrospective study of 157 patients with type 2 diabetes and infectious (wet) foot gangrene, Huang and colleagues (Journal of Foot and Ankle Research, 2018) reported a median survival of 3.12 years and a five-year survival of 40%. Abnormal ankle-brachial index was an independent predictor of major amputation (odds ratio 3.12; 95% CI 1.18–8.24), underscoring how closely gangrene outcomes track perfusion status.
Awaiting Autoamputation: What Is Known
Fikri and colleagues (Diabetes Care, 2011) proposed awaiting autoamputation as a primary management strategy for toe gangrene in diabetic foot disease, and the approach has been discussed in the literature since. A narrative review by Al Wahbi (Diabetes, Metabolic Syndrome and Obesity, 2018) concluded that autoamputation may take several months and that the evidence base is thin, with the review drawing largely on secondary sources and small studies. Individual reports describe successful outcomes: a 2026 case report pair in Archives of Medical Science – Atherosclerosis Diseases described dry gangrene separating spontaneously over approximately two to six months in a critically ill patient and a bedridden patient, with the wounds then healing.
Controlled data are scarce, however. In a retrospective series of 12 patients with diabetic toe gangrene, peripheral artery disease (ankle-brachial index below 0.5), and osteomyelitis, who had failed or declined revascularization, Al Wahbi (Diabetes & Metabolic Syndrome, 2019) found that only one patient achieved autoamputation, at 11 months. Eight patients ultimately required surgical amputation (two above-knee, four below-knee, and two midtarsal), and two patients died during follow-up. Gangrene of the first or second digit was associated with higher-level amputation. The cohort was small, selected for severe disease, and lacked a comparison group, so these findings cannot be generalized to all patients with dry toe gangrene.
The Role of Revascularization and Team-Based Assessment
Because ischemia drives dry gangrene, perfusion assessment is central. The Global Vascular Guidelines on chronic limb-threatening ischemia (Conte et al., European Journal of Vascular and Endovascular Surgery, 2019) define the condition as peripheral artery disease with rest pain, gangrene, or a lower limb ulcer lasting more than two weeks. They recommend urgent referral of patients with suspected chronic limb-threatening ischemia to a vascular specialist, endorse the Wound, Ischemia, and foot Infection (WIfI) staging system, and note that successful revascularization in patients with tissue loss nearly always requires restoration of in-line pulsatile flow to the foot. Whether the gangrene is managed expectantly or surgically, these recommendations place vascular evaluation before decisions about the level of tissue removal.
Level of Amputation and Survival
Amputation level has prognostic implications. In the Huang cohort, median survival was 5.5 years after minor (below-ankle) amputation compared with 1.9 years after major amputation, and five-year survival was 54% versus 30%. Major amputation was independently associated with higher mortality (adjusted hazard ratio 1.80; 95% CI 1.05–3.09). These are observational associations in patients with wet gangrene and may partly reflect underlying illness severity rather than the procedure itself.
Clinical Summary
Evidence on the optimal management of diabetic toe gangrene remains limited to small retrospective series, case reports, and narrative reviews. Autoamputation can occur, but it may take many months, and in one severely ischemic series most patients eventually required surgical amputation. Perfusion status is the most consistent determinant of outcome across the literature, and current vascular guidelines emphasize early specialist assessment for revascularization potential. Wet gangrene, with its association with higher-level amputation and reduced survival, represents a different clinical problem from dry gangrene. Prospective comparative studies are needed to define which patients may safely be observed.
References
- Al Wahbi A. Autoamputation of diabetic toe with dry gangrene: a myth or a fact? Diabetes Metab Syndr Obes. 2018;11:255–264.
- Al Wahbi A. Operative versus non-operative treatment in diabetic dry toe gangrene. Diabetes Metab Syndr. 2019;13(2):959–963.
- Fikri R, Bicknell CD, Bloomfield LM, Lyons SP, Samarasinghe DG. Awaiting autoamputation: a primary management strategy for toe gangrene in diabetic foot disease. Diabetes Care. 2011;34(8):e134.
- Huang YY, Lin CW, Yang HM, Hung SY, Chen IW. Survival and associated risk factors in patients with diabetes and amputations caused by infectious foot gangrene. J Foot Ankle Res. 2018;11:1.
- Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1 Suppl):S1–S109.
- Leivaditis V, Mulita F, Nikolakopoulos K, et al. The waiting game: autoamputation of ischemic lower limbs in non-operative management. Arch Med Sci Atheroscler Dis. 2026;11(1):12–16.
Comments
